Mikihiko Naito Selected Research

Mikihiko Naito Research Topics

Disease

34	Neoplasms (Cancer) 11/2023 - 02/2002
5	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2019 - 10/2007
4	Breast Neoplasms (Breast Cancer) 01/2018 - 11/2013
4	Hypoxia (Hypoxemia) 11/2007 - 01/2003
3	Neoplasm Metastasis (Metastasis) 03/2022 - 09/2008
3	Neuroblastoma 07/2012 - 05/2007
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 02/2024 - 01/2020
2	Duchenne Muscular Dystrophy (Muscular Dystrophy, Becker) 11/2021 - 02/2021
2	Philadelphia Chromosome 01/2020 - 01/2018
2	Genetic Translocation (Chromosomal Translocation) 01/2019 - 08/2017
2	Colitis 01/2018 - 08/2016
2	Myeloid Leukemia (Leukemia, Myelocytic) 01/2018 - 03/2002
2	Diarrhea 01/2018 - 08/2016
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 11/2010 - 04/2008
2	Esophageal Squamous Cell Carcinoma 11/2010 - 04/2008
2	Hepatocellular Carcinoma (Hepatoma) 11/2010 - 04/2008
2	Lung Neoplasms (Lung Cancer) 11/2010 - 04/2008
2	Prion Diseases (Transmissible Spongiform Encephalopathies) 05/2007 - 04/2004
2	Ischemia 03/2007 - 10/2004
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 02/2024
1	Muscular Dystrophies (Muscular Dystrophy) 12/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 12/2022
1	Fibrosarcoma 08/2022
1	Pancreatic Neoplasms (Pancreatic Cancer) 03/2022
1	Chronic Pancreatitis 03/2022
1	Adenocarcinoma 03/2022
1	Glioblastoma (Glioblastoma Multiforme) 01/2022
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2022
1	Cardiomegaly (Heart Hypertrophy) 11/2021
1	Malignant Mesothelioma 01/2021
1	Leukemia 01/2020
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Communicable Diseases (Infectious Diseases) 06/2019
1	Prostatic Neoplasms (Prostate Cancer) 01/2018
1	Alzheimer Disease (Alzheimer's Disease) 12/2014
1	Retinoblastoma (Glioblastoma, Retinal) 01/2014
1	Necrosis 11/2013
1	Acute-Phase Reaction 10/2011

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 02/2024 - 01/2003
5	LigandsIBA 01/2023 - 07/2015
3	Proteolysis Targeting ChimeraIBA 02/2024 - 01/2016
3	Phosphotransferases (Kinase)IBA 01/2023 - 12/2014
3	UbiquitinIBA 08/2022 - 01/2016
3	cellular retinoic acid binding protein IIIBA 03/2022 - 04/2010
3	Estrogen ReceptorsIBA 01/2017 - 07/2015
3	EstersIBA 11/2010 - 04/2008
3	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2007 - 02/2002
3	Vincristine (Oncovin)FDA LinkGeneric 10/2007 - 02/2002
2	prostaglandin R2 D-isomerase (prostaglandin D2 synthase)IBA 12/2022 - 02/2021
2	Proteasome Endopeptidase Complex (Proteasome)IBA 08/2022 - 05/2017
2	CholesterolIBA 03/2022 - 03/2011
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 01/2003
2	Tyrosine Kinase InhibitorsIBA 01/2020 - 01/2020
2	Shiga Toxin (Shigella Toxin)IBA 01/2018 - 08/2016
2	Hormones (Hormone)IBA 01/2018 - 01/2017
2	Virulence Factors (Pathogenicity Factors)IBA 01/2018 - 08/2016
2	CaspasesIBA 01/2018 - 04/2004
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2011 - 02/2002
2	Leucine (L-Leucine)FDA Link 11/2010 - 04/2008
2	Apoptosis Regulatory ProteinsIBA 04/2008 - 10/2004
2	AlbuminsIBA 11/2007 - 03/2007
2	Fluorescein (Funduscein)FDA LinkGeneric 11/2007 - 03/2007
2	Evans Blue (Blue, Evans)FDA Link 11/2007 - 03/2007
2	Quinacrine (Mepacrine)IBA 05/2007 - 04/2004
2	AntibodiesIBA 10/2004 - 01/2003
2	Chelating AgentsIBA 03/2004 - 02/2003
2	CationsIBA 03/2004 - 02/2003
2	Messenger RNA (mRNA)IBA 03/2004 - 02/2003
2	Calcium-Calmodulin-Dependent Protein KinasesIBA 03/2004 - 02/2003
2	Protein Isoforms (Isoforms)IBA 03/2004 - 02/2003
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 03/2002 - 02/2002
1	Anaplastic Lymphoma KinaseIBA 02/2024
1	Transcription Factors (Transcription Factor)IBA 11/2023
1	snake venom protein C activatorIBA 11/2023
1	OligonucleotidesIBA 11/2023
1	fms-Like Tyrosine Kinase 3IBA 12/2022
1	raf KinasesIBA 08/2022
1	Gemcitabine FDA Link 03/2022
1	LipidsIBA 03/2022
1	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022
1	CytokinesIBA 11/2021
1	N- (4- (4- (morpholine- 4- carbonyl)piperidine- 1- yl)phenyl)- 2- phenoxypyrimidine- 5- carboxamideIBA 11/2021
1	narciclasineIBA 01/2021
1	Ubiquitin-Specific ProteasesIBA 01/2020
1	Antimicrobial PeptidesIBA 06/2019
1	Protein Kinases (Protein Kinase)IBA 10/2018
1	bcr-abl Fusion ProteinsIBA 10/2018
1	AndrogensIBA 01/2018
1	X-Linked Inhibitor of Apoptosis ProteinIBA 05/2017
1	Protein AggregatesIBA 05/2017
1	Bortezomib (Velcade)FDA Link 05/2017
1	Ligases (Synthetase)IBA 01/2016
1	humaninIBA 12/2014
1	PhosphoproteinsIBA 01/2014
1	HMGB1 Protein (HMG1)IBA 11/2013
1	Estrogens (Estrogen)FDA Link 11/2013
1	Estrogen Receptor alphaIBA 11/2013

Therapy/Procedure

14	Therapeutics 03/2022 - 01/2003
5	Drug Therapy (Chemotherapy) 01/2021 - 02/2002
3	Radiotherapy 01/2021 - 04/2008